Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Serdar Dursun

Showing results (11-20 of 37) with videos related to

Pageof 4
Sort By:
SAGE Open Medical Case Reports|September 15, 2018
Treating electroconvulsive therapy-induced mania with more electroconvulsive therapy: Evidence for electroconvulsive therapy as the ultra-mood stabilizerRejish K Thomas, Patrick J White, Serdar Dursun
Current Drug Metabolism|June 10, 2008
Metabolism of atypical antipsychotics: involvement of cytochrome p450 enzymes and relevance for drug-drug interactionsLiana Urichuk, Trevor I Prior, Serdar Dursun, et al.
Journal of Psychopharmacology (Oxford, England)|September 6, 2018
Rapid effectiveness of intravenous ketamine for ultraresistant depression in a clinical setting and evidence for baseline anhedonia and bipolarity as clinical predictors of effectivenessRejish K Thomas, Glen Baker, John Lind, et al.
Journal of Psychopharmacology (Oxford, England)|November 11, 2005
Challenges in advancing mental and physical health of patients with serious mental illnessSerdar Dursun, Timothy G Dinan, Chris Bushe, et al.
Revista Brasileira De Psiquiatria (Sao Paulo, Brazil : 1999)|March 7, 2012
Hypoplastic splenium of the corpus callosum and co-occurrence of attention deficit/hyperactivity and language disorders: a case reportEmerson Nunes, Bruno Schneider, Serdar Dursun, et al.
Journal of Psychopharmacology (Oxford, England)|March 20, 2021
Hallucinogenic/psychedelic 5HT2A receptor agonists as rapid antidepressant therapeutics: Evidence and mechanisms of actionRafael Guimarães Dos Santos, Jaime Ec Hallak, Glen Baker, et al.
Psychopharmacology|February 23, 2016
An investigation into aripiprazole's partial D₂ agonist effects within the dorsolateral prefrontal cortex during working memory in healthy volunteersAnna Murphy, Serdar Dursun, Shane McKie, et al.
Biotechnology and Bioengineering|May 9, 2025
RSEA: A Web Server for Pathway Enrichment Analysis of Metabolic Reaction SetsMerve Yarıcı, Furkan Cantürk, Serdar Dursun, et al.
Revista Brasileira De Psiquiatria (Sao Paulo, Brazil : 1999)|February 11, 2011
New perspectives and directions in schizophrenia therapeutics: advances related to non-dopaminergic systemsSaleem Al-Nuaimi, Cristiano Chaves, Jaime E C Hallak, et al.
Health and Quality of Life Outcomes|December 2, 2008
Impact of schizophrenia and schizophrenia treatment-related adverse events on quality of life: direct utility elicitationAndrew Briggs, Diane Wild, Michael Lees, et al.
Pageof 4

Showing results (11-20 of 37) with videos related to

Sort By:
Pageof 4
SAGE Open Medical Case Reports|September 15, 2018
Treating electroconvulsive therapy-induced mania with more electroconvulsive therapy: Evidence for electroconvulsive therapy as the ultra-mood stabilizerRejish K Thomas, Patrick J White, Serdar Dursun
Current Drug Metabolism|June 10, 2008
Metabolism of atypical antipsychotics: involvement of cytochrome p450 enzymes and relevance for drug-drug interactionsLiana Urichuk, Trevor I Prior, Serdar Dursun, et al.
Journal of Psychopharmacology (Oxford, England)|September 6, 2018
Rapid effectiveness of intravenous ketamine for ultraresistant depression in a clinical setting and evidence for baseline anhedonia and bipolarity as clinical predictors of effectivenessRejish K Thomas, Glen Baker, John Lind, et al.
Journal of Psychopharmacology (Oxford, England)|November 11, 2005
Challenges in advancing mental and physical health of patients with serious mental illnessSerdar Dursun, Timothy G Dinan, Chris Bushe, et al.
Revista Brasileira De Psiquiatria (Sao Paulo, Brazil : 1999)|March 7, 2012
Hypoplastic splenium of the corpus callosum and co-occurrence of attention deficit/hyperactivity and language disorders: a case reportEmerson Nunes, Bruno Schneider, Serdar Dursun, et al.
Journal of Psychopharmacology (Oxford, England)|March 20, 2021
Hallucinogenic/psychedelic 5HT2A receptor agonists as rapid antidepressant therapeutics: Evidence and mechanisms of actionRafael Guimarães Dos Santos, Jaime Ec Hallak, Glen Baker, et al.
Psychopharmacology|February 23, 2016
An investigation into aripiprazole's partial D₂ agonist effects within the dorsolateral prefrontal cortex during working memory in healthy volunteersAnna Murphy, Serdar Dursun, Shane McKie, et al.
Biotechnology and Bioengineering|May 9, 2025
RSEA: A Web Server for Pathway Enrichment Analysis of Metabolic Reaction SetsMerve Yarıcı, Furkan Cantürk, Serdar Dursun, et al.
Revista Brasileira De Psiquiatria (Sao Paulo, Brazil : 1999)|February 11, 2011
New perspectives and directions in schizophrenia therapeutics: advances related to non-dopaminergic systemsSaleem Al-Nuaimi, Cristiano Chaves, Jaime E C Hallak, et al.
Health and Quality of Life Outcomes|December 2, 2008
Impact of schizophrenia and schizophrenia treatment-related adverse events on quality of life: direct utility elicitationAndrew Briggs, Diane Wild, Michael Lees, et al.
Pageof 4